Bioventus Inc.BVSNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank42
5Y CAGR-13.3%
Studio
Year-over-Year Change

Price to free cash flow ratio

5Y CAGR
-13.3%/yr
Long-term compound
Percentile
P42
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20256.94-61.8%
202418.16-56.1%
202341.36+487.6%
2022-10.67-103.4%
2021313.61+2114.1%
202014.16-58.0%
201933.72+20.9%
201827.90-
20170.00-
20160.00-